As betting expands into clinical trial outcomes, drugmakers may need to look beyond employees and scrutinize outside partners ...
The FDA recently OK'd Gilead's novel HIV combo med, and cell therapy deals have fallen dramatically in two years.
More than 25 years after it was declared eliminated, measles has surged back. But drug R&D is still in early stages and up ...
Wall Street analysts believe that a more cautious approach to manufacturing, study enrollment and side effect management ...
Two House Republicans are asking the FDA to increase oversight of China-generated clinical data after three trial deaths came ...
Gilead’s new “Up to Date” campaign uses humor and dating scenarios to reach Black communities amid persistent gaps in HIV ...
At the Raritan, New Jersey, facility where Legend Biotech and Johnson & Johnson manufacture Carvykti, a multiple myeloma patient named Colleen met some of the employees who had worked on the CAR-T ...
After two notable failures, the social anxiety R&D space gained a major player when Eli Lilly agreed to acquire AtaiBeckley ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results